All eyes on China Grand in Telix Pharma $175m deal

MELBOURNE: ASX-listed oncology business Telix Pharma’s $175 million raise on Thursday had investors wondering the

To read the full story...SUBSCRIBE NOW

Existing Subscribers Login Below:

Log In
Smarter Selling - specialised sales training for aged care teams